Search

Search Constraints

You searched for: Author/Creator Gernone, Angela

Search Results

1. A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03). Issue 1 (February 2023)

2. Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluation. (February 2018)

3. Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study. (18th June 2021)

4. Dexamethasone‐Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High‐Dose Cisplatin: A Randomized Noninferiority Study. (18th June 2021)

6. GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak. (October 2021)

7. Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. (March 2015)

8. Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. (March 2015)

9. Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. (March 2015)

10. Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer. Issue 2 (January 2016)